Aetna today announced agreements to divest certain Medicare Advantage plans by selling some portions of plans representing about 290,000 enrollees in 21 states to Molina Healthcare Inc., to satisfy Department of Justice concerns about competitive concentration. Molina currently has 4.3 million health plan members, primarily in Medicaid managed care. The insurers’ agreements with Molina are subject to completion of Aetna’s proposed acquisition of Humana and regulatory approvals. Last month DOJ filed a lawsuit in federal court to block Aetna’s proposed acquisition of Humana, citing inadequate divestiture proposals as one reason to block the deal. DOJ also took action to block Anthem’s acquisition of Cigna, saying it would “substantially lessen competition, harming millions of American consumers, as well as doctors and hospitals.” Eight states and the District of Columbia joined DOJ in its action to block the Aetna-Humana deal, while 11 states and the District of Columbia joined the action to block the Anthem-Cigna deal. The deals, if allowed to proceed, would create three major national insurers where there are now five. AHA has vigorously urged DOJ to challenge both deals on the grounds that they would reduce competition and harm consumers and hospitals.

Related News Articles

Headline
The Centers for Medicare & Medicaid Services Dec. 15 published the Measures Under Consideration List for 2025. These are measures that CMS is considering…
Headline
The Medicare Payment Advisory Commission Dec. 4 and 5 discussed draft payment update recommendations for 2027, which the commission will vote on in January.…
Headline
The House Dec. 1 passed the Hospital Inpatient Services Modernization Act (H.R. 4313), legislation extending certain Medicare waivers authorizing the hospital-…
Headline
The Centers for Medicare & Medicaid Services announced Dec. 1 that it intends to expand the Inpatient Rehabilitation Facility Review Choice Demonstration…
Headline
The Centers for Medicare & Medicaid Services Nov. 25 announced lower prices for 15 Medicare Part D drugs selected for the second cycle of negotiations…
Headline
The Centers for Medicare & Medicaid Services Nov. 25 issued a proposed rule for policies governing the Medicare Advantage and Part D programs for 2027. CMS…